SimvaStatin in Neurofibromatosis Type 1- Autism is a research study looking at the use of the drug Simvastatin in children with NF1 and Autism Spectrum Disorders (ASD).
This is a phase II exploratory study of statin treatment in young children aged 5-8 years with NF1 and autism. The purpose of this study is to test acceptability and feasibility of involvement for families and the feasibility of imaging young children with NF1 autism.
We are looking to recruit families from across the country and we currently have links with Liverpool, Leeds and Newcastle Genetic departments.
If you have heard about SANTA and would like to find out more about this exciting trial, see: Interested Families
See: Publications for a full list of our latest papers